Molecular biology of atherosclerosis

PN Hopkins - Physiological reviews, 2013 - journals.physiology.org
At least 468 individual genes have been manipulated by molecular methods to study their
effects on the initiation, promotion, and progression of atherosclerosis. Most clinicians and …

The hemostatic system as a modulator of atherosclerosis

JI Borissoff, HMH Spronk… - New England Journal of …, 2011 - Mass Medical Soc
The Hemostatic System as a Modulator of Atherosclerosis | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

Structure, function and pathophysiology of protease activated receptors

MN Adams, R Ramachandran, MK Yau, JY Suen… - Pharmacology & …, 2011 - Elsevier
Discovered in the 1990s, protease activated receptors 1 (PARs) are membrane-spanning
cell surface proteins that belong to the G protein coupled receptor (GPCR) family. A defining …

Early atherosclerosis exhibits an enhanced procoagulant state

JI Borissoff, S Heeneman, E Kilinç, P Kaššák… - Circulation, 2010 - Am Heart Assoc
Background—Thrombin generation in vivo may be important in regulating atherosclerotic
progression. In the present study, we examined for the first time the activity and presence of …

Cytoprotective activated protein C averts Nlrp3 inflammasome–induced ischemia-reperfusion injury via mTORC1 inhibition

S Nazir, I Gadi, MM Al-Dabet, A Elwakiel… - Blood, The Journal …, 2017 - ashpublications.org
Cytoprotection by activated protein C (aPC) after ischemia-reperfusion injury (IRI) is
associated with apoptosis inhibition. However, IRI is hallmarked by inflammation, and …

Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in …

JI Borissoff, JJT Otten, S Heeneman, P Leenders… - PloS one, 2013 - journals.plos.org
Background Variations in the blood coagulation activity, determined genetically or by
medication, may alter atherosclerotic plaque progression, by influencing pleiotropic effects …

Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes

T Madhusudhan, H Wang, BK Straub… - Blood, The Journal …, 2012 - ashpublications.org
The cytoprotective effects of activated protein C (aPC) are well established. In contrast, the
receptors and signaling mechanism through which aPC conveys cytoprotection in various …

Stabilisation of atherosclerotic plaques

S Ylä-Herttuala, JF Bentzon, M Daemen… - Thrombosis and …, 2011 - thieme-connect.com
Plaque rupture and subsequent thrombotic occlusion of the coronary artery account for as
many as three quarters of myocardial infarctions. The concept of plaque stabilisation …

Coagulation factor and protease pathways in thrombosis and cardiovascular disease

H Ten Cate, TM Hackeng… - Thrombosis and …, 2017 - thieme-connect.com
The biochemical characterisation of the proteolytic pathways that constitute blood
coagulation was one of the most relevant achievements in biomedical research during the …

[HTML][HTML] The impact of blood coagulability on atherosclerosis and cardiovascular disease

R Loeffen, HMH Spronk, H Ten Cate - Journal of Thrombosis and …, 2012 - Elsevier
Although the link between blood coagulation and atherogenesis has been long postulated,
only recently, and through the extensive work on transgenic mice, crossbred on an …